UBS Group AG - RANI THERAPEUTICS HLDGS INC ownership

RANI THERAPEUTICS HLDGS INC's ticker is and the CUSIP is 753018100. A total of 35 filers reported holding RANI THERAPEUTICS HLDGS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of RANI THERAPEUTICS HLDGS INC
ValueSharesWeighting
Q3 2023$12,398
-25.0%
5,700
+42.1%
0.00%
Q2 2023$16,529
+220.3%
4,012
+301.2%
0.00%
Q1 2023$5,160
-12.5%
1,0000.0%0.00%
Q4 2022$5,900
-41.0%
1,0000.0%0.00%
Q3 2022$10,000
-61.5%
1,000
-60.6%
0.00%
Q2 2022$26,000
-45.8%
2,538
-28.9%
0.00%
Q1 2022$48,000
-43.5%
3,570
-31.2%
0.00%
Q4 2021$85,000
+54.5%
5,191
+69.1%
0.00%
Q3 2021$55,0003,0700.00%
Other shareholders
RANI THERAPEUTICS HLDGS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Nan Fung Group Holdings Ltd 493,584$1,073,5450.87%
Alpha Square Group S LLC 86,946$189,1080.19%
LASRY MARC 62,887$136,7790.14%
Alphabet Inc. 448,492$973,2270.06%
UNITED SERVICES AUTOMOBILE ASSOCIATION 481,300$1,034,7950.03%
ISLAY CAPITAL MANAGEMENT, LLC 9,611$20,9040.02%
Activest Wealth Management 9,800$21,3150.01%
Lafayette Investments 19,893$43,2680.01%
MOTCO 48,129$104,6810.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 51,500$112,0130.00%
View complete list of RANI THERAPEUTICS HLDGS INC shareholders